A Notch1neuregulin1 autocrine signaling loop contributes to melanoma growth

K. Zhang, P. Wong, L. Zhang, B. Jacobs, E. C. Borden, J. C. Aster, Barbara Bedogni

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

The Notch pathway is an evolutionary conserved signaling cascade that has an essential role in melanoblast and melanocyte stem cell homeostasis. Notch signaling is emerging as a key player in melanoma, the most deadly form of skin cancer. In melanoma, Notch1 is inappropriately reactivated and contributes to melanoma tumorigenicity. Here, we propose a novel mechanism by which Notch1 promotes the disease. We found that Notch1 directly regulates the transcription of neuregulin1 (NRG1) by binding to its promoter region. NRG1 is the ligand for ERBB3 and 4, members of the epidermal growth factor family of receptors that are involved in the genesis and progression of a number of cancers. Notch1 and NRG1 expression are associated in melanoma and inhibition of NRG1 signaling leads to melanoma cell growth inhibition and tumor growth delay. Mechanistically, these effects are associated with the inhibition of the PI3Kinase/Akt signaling pathway and with the accumulation of p27 Kip1. On the other end, addition of recombinant NRG1 can partially restore melanoma cell growth that is inhibited by Notch1 ablation. Taken together, our findings underline a new, previously undescribed autocrine signaling loop between Notch1 and NRG1 that controls melanoma growth and provide experimental evidence that the targeting of Notch and ERBB signaling may represent a novel potential therapeutic approach in melanoma.

Original languageEnglish (US)
Pages (from-to)4609-4618
Number of pages10
JournalOncogene
Volume31
Issue number43
DOIs
StatePublished - Oct 25 2012
Externally publishedYes

Fingerprint

Autocrine Communication
Melanoma
Growth
Melanocytes
Skin Neoplasms
Genetic Promoter Regions
Neoplasms
Homeostasis
Stem Cells
Ligands

Keywords

  • ERBB: erythroblastic leukemia viral oncogene homolog or EGF (epidermal growth factor) family of transmembrane receptor tyrosine kinases
  • NIC: Notch1 intracellular domain
  • Notch1-TM: transmembrane Notch1
  • NRG1: neuregulin1
  • p27KIP1: CDKN1B: cyclin-dependent kinase inhibitor 1B

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Cancer Research

Cite this

Zhang, K., Wong, P., Zhang, L., Jacobs, B., Borden, E. C., Aster, J. C., & Bedogni, B. (2012). A Notch1neuregulin1 autocrine signaling loop contributes to melanoma growth. Oncogene, 31(43), 4609-4618. https://doi.org/10.1038/onc.2011.606

A Notch1neuregulin1 autocrine signaling loop contributes to melanoma growth. / Zhang, K.; Wong, P.; Zhang, L.; Jacobs, B.; Borden, E. C.; Aster, J. C.; Bedogni, Barbara.

In: Oncogene, Vol. 31, No. 43, 25.10.2012, p. 4609-4618.

Research output: Contribution to journalArticle

Zhang, K, Wong, P, Zhang, L, Jacobs, B, Borden, EC, Aster, JC & Bedogni, B 2012, 'A Notch1neuregulin1 autocrine signaling loop contributes to melanoma growth', Oncogene, vol. 31, no. 43, pp. 4609-4618. https://doi.org/10.1038/onc.2011.606
Zhang K, Wong P, Zhang L, Jacobs B, Borden EC, Aster JC et al. A Notch1neuregulin1 autocrine signaling loop contributes to melanoma growth. Oncogene. 2012 Oct 25;31(43):4609-4618. https://doi.org/10.1038/onc.2011.606
Zhang, K. ; Wong, P. ; Zhang, L. ; Jacobs, B. ; Borden, E. C. ; Aster, J. C. ; Bedogni, Barbara. / A Notch1neuregulin1 autocrine signaling loop contributes to melanoma growth. In: Oncogene. 2012 ; Vol. 31, No. 43. pp. 4609-4618.
@article{39224be659ba46019be2d7ccceb6bed0,
title = "A Notch1neuregulin1 autocrine signaling loop contributes to melanoma growth",
abstract = "The Notch pathway is an evolutionary conserved signaling cascade that has an essential role in melanoblast and melanocyte stem cell homeostasis. Notch signaling is emerging as a key player in melanoma, the most deadly form of skin cancer. In melanoma, Notch1 is inappropriately reactivated and contributes to melanoma tumorigenicity. Here, we propose a novel mechanism by which Notch1 promotes the disease. We found that Notch1 directly regulates the transcription of neuregulin1 (NRG1) by binding to its promoter region. NRG1 is the ligand for ERBB3 and 4, members of the epidermal growth factor family of receptors that are involved in the genesis and progression of a number of cancers. Notch1 and NRG1 expression are associated in melanoma and inhibition of NRG1 signaling leads to melanoma cell growth inhibition and tumor growth delay. Mechanistically, these effects are associated with the inhibition of the PI3Kinase/Akt signaling pathway and with the accumulation of p27 Kip1. On the other end, addition of recombinant NRG1 can partially restore melanoma cell growth that is inhibited by Notch1 ablation. Taken together, our findings underline a new, previously undescribed autocrine signaling loop between Notch1 and NRG1 that controls melanoma growth and provide experimental evidence that the targeting of Notch and ERBB signaling may represent a novel potential therapeutic approach in melanoma.",
keywords = "ERBB: erythroblastic leukemia viral oncogene homolog or EGF (epidermal growth factor) family of transmembrane receptor tyrosine kinases, NIC: Notch1 intracellular domain, Notch1-TM: transmembrane Notch1, NRG1: neuregulin1, p27KIP1: CDKN1B: cyclin-dependent kinase inhibitor 1B",
author = "K. Zhang and P. Wong and L. Zhang and B. Jacobs and Borden, {E. C.} and Aster, {J. C.} and Barbara Bedogni",
year = "2012",
month = "10",
day = "25",
doi = "10.1038/onc.2011.606",
language = "English (US)",
volume = "31",
pages = "4609--4618",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "43",

}

TY - JOUR

T1 - A Notch1neuregulin1 autocrine signaling loop contributes to melanoma growth

AU - Zhang, K.

AU - Wong, P.

AU - Zhang, L.

AU - Jacobs, B.

AU - Borden, E. C.

AU - Aster, J. C.

AU - Bedogni, Barbara

PY - 2012/10/25

Y1 - 2012/10/25

N2 - The Notch pathway is an evolutionary conserved signaling cascade that has an essential role in melanoblast and melanocyte stem cell homeostasis. Notch signaling is emerging as a key player in melanoma, the most deadly form of skin cancer. In melanoma, Notch1 is inappropriately reactivated and contributes to melanoma tumorigenicity. Here, we propose a novel mechanism by which Notch1 promotes the disease. We found that Notch1 directly regulates the transcription of neuregulin1 (NRG1) by binding to its promoter region. NRG1 is the ligand for ERBB3 and 4, members of the epidermal growth factor family of receptors that are involved in the genesis and progression of a number of cancers. Notch1 and NRG1 expression are associated in melanoma and inhibition of NRG1 signaling leads to melanoma cell growth inhibition and tumor growth delay. Mechanistically, these effects are associated with the inhibition of the PI3Kinase/Akt signaling pathway and with the accumulation of p27 Kip1. On the other end, addition of recombinant NRG1 can partially restore melanoma cell growth that is inhibited by Notch1 ablation. Taken together, our findings underline a new, previously undescribed autocrine signaling loop between Notch1 and NRG1 that controls melanoma growth and provide experimental evidence that the targeting of Notch and ERBB signaling may represent a novel potential therapeutic approach in melanoma.

AB - The Notch pathway is an evolutionary conserved signaling cascade that has an essential role in melanoblast and melanocyte stem cell homeostasis. Notch signaling is emerging as a key player in melanoma, the most deadly form of skin cancer. In melanoma, Notch1 is inappropriately reactivated and contributes to melanoma tumorigenicity. Here, we propose a novel mechanism by which Notch1 promotes the disease. We found that Notch1 directly regulates the transcription of neuregulin1 (NRG1) by binding to its promoter region. NRG1 is the ligand for ERBB3 and 4, members of the epidermal growth factor family of receptors that are involved in the genesis and progression of a number of cancers. Notch1 and NRG1 expression are associated in melanoma and inhibition of NRG1 signaling leads to melanoma cell growth inhibition and tumor growth delay. Mechanistically, these effects are associated with the inhibition of the PI3Kinase/Akt signaling pathway and with the accumulation of p27 Kip1. On the other end, addition of recombinant NRG1 can partially restore melanoma cell growth that is inhibited by Notch1 ablation. Taken together, our findings underline a new, previously undescribed autocrine signaling loop between Notch1 and NRG1 that controls melanoma growth and provide experimental evidence that the targeting of Notch and ERBB signaling may represent a novel potential therapeutic approach in melanoma.

KW - ERBB: erythroblastic leukemia viral oncogene homolog or EGF (epidermal growth factor) family of transmembrane receptor tyrosine kinases

KW - NIC: Notch1 intracellular domain

KW - Notch1-TM: transmembrane Notch1

KW - NRG1: neuregulin1

KW - p27KIP1: CDKN1B: cyclin-dependent kinase inhibitor 1B

UR - http://www.scopus.com/inward/record.url?scp=84867897035&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867897035&partnerID=8YFLogxK

U2 - 10.1038/onc.2011.606

DO - 10.1038/onc.2011.606

M3 - Article

C2 - 22249266

AN - SCOPUS:84867897035

VL - 31

SP - 4609

EP - 4618

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 43

ER -